Anika Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $240.2M
Liabilities Breakdown FY2016
Total Liabilities: $17.5M
Asset Breakdown
Total Assets: $240.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $104.3M | 43.4% |
| Accounts Receivable | $27.6M | 11.5% |
| Inventory | $16.0M | 6.7% |
| Property, Plant & Equipment | $52.3M | 21.8% |
| Goodwill | $7.2M | 3.0% |
| Intangible Assets | $10.2M | 4.3% |
| Other Assets | $22.7M | 9.4% |
Liabilities Breakdown
Total Liabilities: $17.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.3M | 13.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $15.2M | 86.8% |